Actual Medicinal Product (AMP) - Hypovase 1mg tablets (Pfizer Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Current Name | Hypovase 1mg tablets | SOT | |
Summary
- Discontinued
- Licensed Route
- Oral
- Availability Restrictions
- Not available
- Licensing Authority
- Medicines - MHRA/EMA
Codes
| BNF | Start Date | End Date |
|---|---|---|
| Previous BNF 02050400 | Start Date 01-06-2005 | End Date 03-04-2022 |
| Previous BNF 02060401 | Start Date 01-06-2005 | End Date 03-04-2022 |
| Previous BNF 07040100 | Start Date 01-06-2005 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 347411000001101 | SOT |
Parent Products
-
VTMPrazosin
-
VMPPrazosin 1mg tablets
-
AMP(Current) Hypovase 1mg tablets (Pfizer Ltd) (Other AMPs)
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 32 tablet | ||
| 56 tablet | ||
| 60 tablet |